Jean-Pierre Bizzari is a Doctor of Medicine, graduate of the Nice Medical School and a specialist in oncology. Since October 2008, he has served as Senior Vice President for Clinical Development Oncology at Celgene, and is based in the USA.

Between 1993 and 2008 he held the same position successively at Rhône-Poulenc Rorer, Aventis, Sanofi-Synthélabo, and Sanofi-Aventis, also in the USA. He was responsible for the clinical development of drugs such as Taxotere or Eloxatin. After working as an assistant in the medical oncology department at La Pitié-Salpêtrière hospital in Paris, Dr Bizzari became head of the oncology department at Servier.

Since 2005 he has been a member of the international scientific committee of the French National Cancer Research Institute.

Innovation, Journalism, Futurism, Business Leadership, Technology, Editing, Inventors, Oncology, Authors, Engineering, Filmmaking Media Professionals,